Literature DB >> 7201885

Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.

L Weiselberg, D R Budman, P Schulman, V Vinciguerra, T J Degnan, M Pasmantier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7201885

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

Review 1.  Developing new drugs for ovarian cancer: a challenging task in a changing reality.

Authors:  R M Canetta; S K Carter
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

2.  Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro.

Authors:  B T Hill; A S Bellamy; S Metcalfe; P J Hepburn; J R Masters; R D Whelan
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.